Last updated: 17 July 2019 at 8:12am EST

Ron Laufer Net Worth




The estimated Net Worth of Ron Laufer is at least $13.9 million dollars as of 30 June 2015. Ron Laufer owns over 223,439 units of Astria Therapeutics Inc stock worth over $13,942,848 and over the last 9 years Ron sold CATB stock worth over $0.

Ron Laufer CATB stock SEC Form 4 insiders trading

Ron has made over 2 trades of the Astria Therapeutics Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Ron bought 223,439 units of CATB stock worth $2,681,268 on 30 June 2015.

The largest trade Ron's ever made was buying 223,439 units of Astria Therapeutics Inc stock on 30 June 2015 worth over $2,681,268. On average, Ron trades about 223,439 units every 0 days since 2015. As of 30 June 2015 Ron still owns at least 1,632,652 units of Astria Therapeutics Inc stock.

You can see the complete history of Ron Laufer stock trades at the bottom of the page.



What's Ron Laufer's mailing address?

Ron's mailing address filed with the SEC is C/O MEDIMMUNE VENTURES, INC., ONE MEDIMMUNE WAY, GAITHERSBURG, MD, 20878.

Insiders trading at Astria Therapeutics Inc

Over the last 9 years, insiders at Astria Therapeutics Inc have traded over $0 worth of Astria Therapeutics Inc stock and bought 3,064,797 units worth $36,777,564 . The most active insiders traders include Jean George, Nicholas Galakatos et Lifesciences Ii, L.P.Clarus.... On average, Astria Therapeutics Inc executives and independent directors trade stock every 0 days with the average trade being worth of $2,617,339. The most recent stock trade was executed by Lifesciences Ii, L.P.Clarus... on 30 June 2015, trading 376,695 units of CATB stock currently worth $4,520,340.



What does Astria Therapeutics Inc do?



Complete history of Ron Laufer stock trades at Astria Therapeutics Inc

Initié
Trans.
Transaction
Prix ​​total
Ron Laufer
Directeur
Acheter $2,681,268
30 Jun 2015
Ron Laufer
Directeur
Acheter $2,681,268
30 Jun 2015


Astria Therapeutics Inc executives and stock owners

Astria Therapeutics Inc executives and other stock owners filed with the SEC include: